Interleukin-2 Inc said theregistration of warrants became effective March 20 and that 3.5mln warrants will be convertible into 1.75 mln shares of thecompany's common stock, giving the company a maximum of 2.4 mlndlrs.    The warrants must be exercised by June 22. Reuter&#3;